Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation.
Liu
Tong
T
Li
Guangping
G
Xu
Gang
G
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000975:Antioxidants / Q000502:physiology* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control*; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan